ZOGHBI HUDA Y sold 32.0% of their position (800.00 shares) of REGENERON PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $640.0K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/12/2026ACC: 0001681643-26-000006
Director
Since Jan 2019
-800.00
Net shares
Net seller
$640.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
800.00 acquired · 1.60K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+800.00
Price / share
$376.69
Trade value
$301.35K
% of position
47.0%
8/10/2026
1.70K→2.50K
Common Stock
Direct
Shares
−800.00
Price / share
$800.00
Trade value
$640K
% of position
32.0%
8/10/2026
2.50K→1.70K
Total
Net shares
+0.00
Net value
-$338.65K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/10/2026 | M · Option Exercise | +800.00 | $376.69 | $301.35K | 47.0% | 1.70K | 2.50K |
| Common Stock Direct | 8/10/2026 | S · Sale | −800.00 | $800.00 | $640K | 32.0% | 2.50K | 1.70K |
| Total | +0.00 | -$338.65K | ||||||
Derivative Transactions1
Non-Qualified Stock Option (right to buy)
Direct
Converts to
Common Stock
800.00 shares
Shares
−800.00
Strike price
376.69
Held after
0.00
Exercisable
—
8/10/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) Direct | Common Stock800.00 shares | 8/10/2026 | M · Option Exercise | −800.00 | 376.69 | — | 0.00 |